Technology in Diagnostics & Care

We use unique and innovative tools for the early diagnosis and prognosis of Parkinson’s and Alzheimer’s disease and for monitoring the progression of motor and memory symptoms and the response to treatment.

Access to several cutting-edge biomarkers and those composed of our innovative and sensitive biomarker tools termed PRECODE-1 and PRECODE-2 (with or without the addition of genetic profiling) are designed to significantly benefit management and planning efficient approaches to treatment for patients and people at risk.